Cleared Traditional

K231192 - RIGHTEST Blood Glucose Monitoring System Max Tel (FDA 510(k) Clearance)

Jan 2024
Decision
267d
Days
Class 2
Risk

K231192 is an FDA 510(k) clearance for the RIGHTEST Blood Glucose Monitoring System Max Tel. This device is classified as a System, Test, Blood Glucose, Over The Counter (Class II - Special Controls, product code NBW).

Submitted by Bionime Corporation (Taichung City, TW). The FDA issued a Cleared decision on January 19, 2024, 267 days after receiving the submission on April 27, 2023.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K231192 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 2023
Decision Date January 19, 2024
Days to Decision 267 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code NBW — System, Test, Blood Glucose, Over The Counter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345

Similar Devices — NBW System, Test, Blood Glucose, Over The Counter

All 13
On Call® Sure GK Blood Glucose & Ketone Monitoring System
K250085 · ACON Laboratories, Inc. · Oct 2025
RIGHTEST Blood Glucose Monitoring System Max Tel
K240637 · Bionime Corporation · Nov 2024
ReliOn Premier BLU Blood Glucose Monitoring System
K230625 · I-Sens, Inc. · Aug 2023
GlucoSure ADVANCE Link Blood Glucose Monitoring System
K222234 · Apex BioTechnology Corp. · Dec 2022
BGM039 Blood Glucose Monitoring System, BGM039 Link Blood Glucose Monitoring System
K220421 · Apex BioTechnology Corp. · Nov 2022
GlucoSure Link Blood Glucose Monitoring System
K212140 · Apex BioTechnology Corp. · Aug 2022